Paragon Bioservices, Inc.
Elizabeth Thompson is an experienced professional with a strong background in manufacturing and research within the pharmaceutical and academic sectors. Currently serving as a Supervisor and Manufacturing Associate II at Catalent Pharma Solutions since September 2019, Elizabeth has held various positions including Qualified Trainer and Manufacturing Team Lead. Concurrently, Elizabeth has worked as a Manufacturing Associate at Paragon Bioservices, Inc. from September 2019. Prior roles include a Research Assistant at the University of Mississippi specializing in environmental toxicology and breast cancer research, and community-focused positions such as Community Desk Assistant and Community Assistant at the University. Elizabeth holds a degree in Biochemistry with minors in Biology and Anthropology from the University of Mississippi, complemented by early education at Mount de Sales Academy for Girls.
Paragon Bioservices, Inc.
With deep experience in viral vector scale-up and production, Catalent Cell & Gene Therapy is a full-service partner for adeno-associated virus (AAV) and lentiviral vectors, and CAR-T immunotherapies. When it acquired MaSTherCell, Catalent added expertise in autologous and allogeneic cell therapy development and manufacturing to position it as a premier technology, development and manufacturing partner for innovators across the entire field of advanced biotherapeutics. Catalent has a global cell and gene therapy network of dedicated, large-scale clinical and commercial manufacturing facilities, and fill-finish and packaging capabilities located in both the U.S. and Europe. An experienced partner, Catalent Cell & Gene Therapy has worked with industry leaders across 70+ clinical and commercial programs.